Extended Cytogenetic Follow-up and Clinical Progress in Patients with Myelodysplastic Syndromes (MDS)
about
Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome.Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.Pathogenetic Aspects of Myelodysplastic Syndromes.
P2860
Extended Cytogenetic Follow-up and Clinical Progress in Patients with Myelodysplastic Syndromes (MDS)
description
im Februar 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 February 1994
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1994
@uk
name
Extended Cytogenetic Follow-up ...... yelodysplastic Syndromes (MDS)
@en
Extended Cytogenetic Follow-up ...... with Myelodysplastic Syndromes
@nl
type
label
Extended Cytogenetic Follow-up ...... yelodysplastic Syndromes (MDS)
@en
Extended Cytogenetic Follow-up ...... with Myelodysplastic Syndromes
@nl
prefLabel
Extended Cytogenetic Follow-up ...... yelodysplastic Syndromes (MDS)
@en
Extended Cytogenetic Follow-up ...... with Myelodysplastic Syndromes
@nl
P2093
P2860
P1433
P1476
Extended cytogenetic follow-up ...... yelodysplastic syndromes (MDS)
@en
P2093
P2860
P304
P356
10.3109/10428199409073781
P577
1994-02-01T00:00:00Z